Recent publications
Article
Manukjan, N, Majcher, D, Leenders, P, Caiment, F, van Herwijnen, M, Smeets, HJ, Suidgeest, E, van der Weerd, L, Vanmierlo, T, Jansen, JFA, Backes, WH, van Oostenbrugge, RJ, Staals, J, Fulton, D, Ahmed, Z, Blankesteijn, WM & Foulquier, S 2023, 'Hypoxic oligodendrocyte precursor cell-derived VEGFA is associated with blood–brain barrier impairment', Acta Neuropathologica Communications, vol. 11, no. 1, 128. https://doi.org/10.1186/s40478-023-01627-5
Toth, E, Rassul, S, Berry, M & Fulton, D 2021, 'A morphological analysis of activity-dependent myelination and myelin injury in transitional oligodendrocytes', Scientific Reports, vol. 11, no. 1, 9588. https://doi.org/10.1038/s41598-021-88887-0
Otsu, M, Ahmed, Z & Fulton, D 2021, 'Generation of multipotential NG2 progenitors from mouse embryonic stem cell- derived neural stem cells', Frontiers in cell and developmental biology, vol. 9, 688283. https://doi.org/10.3389/fcell.2021.688283
Begum, G, Otsu, M, Ahmed, U, Ahmed, Z, Stevens, A & Fulton, D 2018, 'NF‐Y‐dependent regulation of glutamate receptor 4 expression and cell survival in cells of the oligodendrocyte lineage', GLIA. https://doi.org/10.1002/glia.23446
Fannon, J, Tamier, W & Fulton, D 2015, 'Neuronal activity and AMPA-type glutamate receptor activation regulates the morphological development of oligodendrocyte precursor cells', GLIA, vol. 63, no. 6, pp. 1021-1035. https://doi.org/10.1002/glia.22799
Leoni, G, Rattray, M, Fulton, D, Rivera, A & Butt, AM 2014, 'Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan', Journal of Anatomy, vol. 224, no. 2, pp. 216-227. https://doi.org/10.1111/joa.12141
Paez, PM, Fulton, D, Spreuer, V, Handley, V & Campagnoni, AT 2011, 'Modulation of canonical transient receptor potential channel 1 in the proliferation of oligodendrocyte precursor cells by the golli products of the myelin basic protein gene', The Journal of Neuroscience, vol. 31, no. 10, pp. 3625-37. https://doi.org/10.1523/JNEUROSCI.4424-10.2011
Editorial
Ahmed, Z, Fulton, D & Douglas, M 2020, 'Opicinumab: is it a potential treatment for multiple sclerosis?', Annals of Translational Medicine. https://doi.org/10.21037/atm.2020.03.131
Other contribution
Toth, E, Rassul, SM, Berry, M & Fulton, D 2019, A morphological analysis of activity-dependent myelination and myelin injury in transitional oligodendrocytes.. https://doi.org/10.1101/750083
Review article
Grech, O, Mollan, S, Wakerley, B, Fulton, D, Lavery, G & Sinclair, A 2021, 'The role of metabolism in migraine pathophysiology and susceptibility', Life: Physiology and Pathology, vol. 11, no. 5, 415. https://doi.org/10.3390/life11050415
Manukjan, N, Ahmed, Z, Fulton, D, Blankesteijn, WM & Foulquier, S 2020, 'A Systematic Review of WNT Signaling in Endothelial Cell Oligodendrocyte Interactions: Potential Relevance to Cerebral Small Vessel Disease', Cells, vol. 9, no. 6, 1545. https://doi.org/10.3390/cells9061545
Ceprian, M & Fulton, D 2019, 'Glial Cell AMPA receptors in nervous system health, injury and disease', International Journal of Molecular Sciences, vol. 20, no. 10, 2450. https://doi.org/0.3390/ijms20102450
Foale, S, Berry, M, Logan, A, Fulton, D & Ahmed, Z 2017, 'LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders?', Neural Regeneration Research, vol. 12, no. 8, pp. 1247-1251. https://doi.org/10.4103/1673-5374.213538
Berry, M, Ahmed, Z, Morgan-Warren, P, Fulton, D & Logan, A 2016, 'Prospects for mTOR-mediated functional repair after central nervous system trauma', Neurobiology of Disease, vol. 85, pp. 99-110. https://doi.org/10.1016/j.nbd.2015.10.002
Rassul, S, Neely, R & Fulton, D 2015, 'Live-imaging in the CNS: new insights on oligodendrocytes, myelination, and their responses to inflammation', Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2015.09.011
View all publications in research portal